Mankind Pharma (BOM:543904) COGS-to-Revenue : 0.30 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Mankind Pharma COGS-to-Revenue?

Mankind Pharma's Cost of Goods Sold for the three months ended in Mar. 2024 was ₹7,373 Mil. Its Revenue for the three months ended in Mar. 2024 was ₹24,411 Mil.

Mankind Pharma's COGS to Revenue for the three months ended in Mar. 2024 was 0.30.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Mankind Pharma's Gross Margin % for the three months ended in Mar. 2024 was 69.80%.

Mankind Pharma COGS-to-Revenue Historical Data

The historical data trend for Mankind Pharma's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mankind Pharma COGS-to-Revenue Chart

Mankind Pharma Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

COGS-to-Revenue

0.33

0.29

0.32

0.33

0.31

Mankind Pharma Quarterly Data
	Mar20	Mar21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial							0.33	0.32	0.30	0.32	0.30

Mankind Pharma COGS-to-Revenue Calculation

Mankind Pharma's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	32096.959	/	103347.746
	=	0.31

Mankind Pharma's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	7372.885	/	24410.992
	=	0.30

Mankind Pharma (BOM:543904) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Mankind Pharma's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	7372.885 / 24410.992
	=	69.80 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Mankind Pharma COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Mankind Pharma's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Mankind Pharma (BOM:543904) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mankind Pharma Ltd (BOM:543904) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

MANKIND:India

Address

262, Okhla Industrial Estate, Phase-III, New Delhi, IND, 110020

Website

https://www.mankindpharma.com

Mankind Pharma Ltd is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices and has an established track record of building and scaling brands in-house. The company's brands include Manforce, Prega News and Gas-O-Fast.

Mankind Pharma (BOM:543904) Headlines

No Headlines